Hospital
John C Fremont Healthcare District
John C Fremont Healthcare District was paid $925K by Medicaid between Jan 2018 and Dec 2023, across 71 billing codes. Its largest line is 0450, Emergency room services — 25% of everything it billed.
33Billing provider infoJOHN C FREMONT HEALTHCARE DISTRICT
MARIPOSA, CA 95338
MARIPOSA, CA 95338
33aNPI1184662652assigned 06/04/2006
33bProvider typeCritical Access Hospital
28Total paid$925K
24GClaims50,914
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Critical Access Hospital providers in California
Rank by total paid#25 of 30
Median peer was paid$3.14M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,004 | $178K | |
| 2019 | 9,853 | $158K | |
| 2020 | 11,247 | $167K | |
| 2021 | 7,050 | $165K | |
| 2022 | 5,818 | $117K | |
| 2023 | 6,942 | $140K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 25% | 4,609 | 4,276 | $234K |
| 99199 | Unlisted special service, procedure or report | 11% | 2,140 | 2,071 | $106K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.6% | 825 | 768 | $80K |
| 80053 | Comprehensive metabolic panel | 8.3% | 5,482 | 5,112 | $77K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.6% | 2,492 | 2,466 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.7% | 4,736 | 4,441 | $43K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 4.6% | 1,819 | 909 | $43K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.7% | 1,408 | 1,405 | $34K |
| 80061 | Lipid panel | 3.4% | 2,331 | 2,325 | $31K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.5% | 1,957 | 1,950 | $23K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.0% | 75 | 75 | $18K |
| 0250 | 1.9% | 1,436 | 980 | $17K |
59 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 677 | $15K |
| 84439 | 1.4% | 1,149 | $13K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 120 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 414 | $10K |
| 99283 | Emergency room visit (moderate) | <1% | 132 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 189 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 428 | $8K |
| 83735 | <1% | 919 | $7K | |
| 81001 | <1% | 1,290 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 154 | $5K |
| 0270 | <1% | 1,251 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 215 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 566 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 146 | $4K |
| 83690 | <1% | 250 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 634 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 76 | $4K |
| 87430 | <1% | 242 | $3K | |
| 82607 | <1% | 508 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 17 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 305 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 76 | $3K |
| 81002 | <1% | 919 | $3K | |
| 84484 | <1% | 209 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 212 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 43 | $2K |
| 87070 | <1% | 194 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 16 | $2K |
| 83605 | <1% | 138 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 46 | $2K |
| 85610 | <1% | 381 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 93 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 25 | $1K |
| 81003 | <1% | 438 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,015 | $1K |
| 82043 | <1% | 113 | $835.11 | |
| 85027 | <1% | 118 | $830.61 | |
| 0272 | <1% | 449 | $683.51 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 34 | $662.65 |
| 85651 | <1% | 177 | $651.28 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 121 | $640.13 |
| 81025 | <1% | 100 | $545.42 | |
| 83880 | <1% | 16 | $432.47 | |
| 99001 | <1% | 1,571 | $428.40 | |
| 82550 | <1% | 53 | $416.78 | |
| 85730 | <1% | 56 | $406.81 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 81 | $404.39 |
| J3490 | Unclassified drugs | <1% | 528 | $399.09 |
| 86140 | <1% | 58 | $349.81 | |
| 0271 | <1% | 173 | $319.54 | |
| 87077 | <1% | 69 | $270.88 | |
| 87186 | <1% | 39 | $208.66 | |
| 85007 | <1% | 58 | $179.54 | |
| 83550 | <1% | 20 | $160.08 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 26 | $136.87 |
| 0258 | <1% | 48 | $130.50 | |
| 82150 | <1% | 14 | $110.56 | |
| 80377 | <1% | 168 | $66.60 | |
| 0259 | <1% | 27 | $20.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMACPHEE, ALAN (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| John C. Fremont Healthcare District | Mariposa, CA | $2.28M |
| John C. Fremont Healthcare District | Mariposa, CA | $1.36M |
| John C. Fremont Healthcare District | Mariposa, CA | $956K |
| John C Fremont Healthcare District | Mariposa, CA | $378K |
| John C. Fremont Healthcare District | Mariposa, CA | $216K |
| John C. Fremont Healthcare District | Coulterville, CA | $149K |
| John C Fremont Healthcare District | Coulterville, CA | $8K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.